Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

froxlor — Vulnerabilities & Security Advisories 12

All 12 CVE vulnerabilities found in froxlor, with AI-generated Chinese analysis, references, and POCs.

Vendor: Froxlor

CVE IDTitleCVSSSeverityPublished
CVE-2026-41233 Froxlor has a Reseller Domain Quota Bypass via Unvalidated adminid Parameter in Domains.add() CWE-863 5.4 Medium2026-04-23
CVE-2026-41232 Froxlor has an Email Sender Alias Domain Ownership Bypass via Wrong Array Index that Allows Cross-Customer Email Spoofing CWE-863 5.0 Medium2026-04-23
CVE-2026-41231 Froxlor has Incomplete Symlink Validation in DataDump.add() that Allows Arbitrary Directory Ownership Takeover via Cron CWE-59 7.5 High2026-04-23
CVE-2026-41230 Froxlor has a BIND Zone File Injection via Unsanitized DNS Record Content in DomainZones::add() CWE-93 8.5 High2026-04-23
CVE-2026-41229 Froxlor has a PHP Code Injection via Unescaped Single Quotes in userdata.inc.php Generation (MysqlServer API) CWE-94 9.1 Critical2026-04-23
CVE-2026-41228 Froxlor has Local File Inclusion via path traversal in API `def_language` parameter that leads to Remote Code Execution CWE-98 10.0 Critical2026-04-23
CVE-2026-30932 Froxlor is vulnerable to BIND zone file injection via unsanitized DNS record content in DomainZones API CWE-74 7.5 -2026-03-24
CVE-2026-26279 Froxlor Admin-to-Root Privilege Escalation via Input Validation Bypass + OS Command Injection CWE-78 9.1 Critical2026-03-03
CVE-2025-48958 Froxlor has an HTML Injection Vulnerability CWE-79 5.5 Medium2025-06-02
CVE-2025-29773 Froxlor allows Multiple Accounts to Share the Same Email Address Leading to Potential Privilege Escalation or Account Takeover CWE-287 5.8 Medium2025-03-13
CVE-2024-34070 Froxlor Vulnerable to Blind XSS Leading to Froxlor Application Compromise CWE-79 9.7 Critical2024-05-10
CVE-2023-50256 Froxlor username/surname AND company field Bypass CWE-20 7.5 High2024-01-03

All 12 known CVE vulnerabilities affecting froxlor with full Chinese analysis, references, and POCs where available.